NATURAL HEALTH TRENDS CORP Earnings Per Share Disclosure
3. NET INCOME (LOSS) PER COMMON SHARE
The following table illustrates the computation of basic and diluted net income (loss) per common share for the periods indicated (in thousands, except per share data):
| Year Ended December 31, | ||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||
| Loss | Shares | Per Share | Income | Shares | Per Share | |||||||||||||||||||
| Basic net income (loss) per common share: | ||||||||||||||||||||||||
| Net income (loss) available to common stockholders | $ | (882 | ) | 11,496 | $ | (0.08 | ) | $ | 572 | 11,467 | $ | 0.05 | ||||||||||||
| Effect of dilutive securities: | ||||||||||||||||||||||||
| Non-vested restricted stock | — | — | — | 23 | ||||||||||||||||||||
| Diluted net income (loss) per common share: | ||||||||||||||||||||||||
| Net income (loss) available to common stockholders plus assumed dilution | $ | (882 | ) | 11,496 | $ | (0.08 | ) | $ | 572 | 11,490 | $ | 0.05 | ||||||||||||
In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive. As such, non-vested restricted stock totaling 8,063 shares were not included for 2025.
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.